Paroxetine maleate
Paroxetine maleate structure
|
Common Name | Paroxetine maleate | ||
|---|---|---|---|---|
| CAS Number | 64006-44-6 | Molecular Weight | 445.44 | |
| Density | 1.213 g/cm3 | Boiling Point | 451.7ºC at 760 mmHg | |
| Molecular Formula | C23H24FNO7 | Melting Point | 136-138ºC | |
| MSDS | Chinese USA | Flash Point | 227ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of Paroxetine maleateParoxetine maleate is a potent and selective inhibitor of SSRI. Paroxetine maleate is used in generalized anxiety disorder, post traumatic stress disorder, premenstrual dysphoric disorder and chronic headache research[1]. |
| Name | paroxetine maleate |
|---|---|
| Synonym | More Synonyms |
| Description | Paroxetine maleate is a potent and selective inhibitor of SSRI. Paroxetine maleate is used in generalized anxiety disorder, post traumatic stress disorder, premenstrual dysphoric disorder and chronic headache research[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Bourin M, et al. Paroxetine: a review. CNS Drug Rev. 2001 Spring;7(1):25-47. |
| Density | 1.213 g/cm3 |
|---|---|
| Boiling Point | 451.7ºC at 760 mmHg |
| Melting Point | 136-138ºC |
| Molecular Formula | C23H24FNO7 |
| Molecular Weight | 445.44 |
| Flash Point | 227ºC |
| Exact Mass | 445.15400 |
| PSA | 114.32000 |
| LogP | 3.36710 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R22;R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | UN 3249 |
| WGK Germany | 3 |
| RTECS | TM4569300 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
|
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
J. Clin. Psychopharmacol. 33(1) , 3-10, (2013) The potential for iloperidone, a D2/5-HT2A antipsychotic, to affect the heart rate-corrected QT interval (QTc) was assessed in the absence and presence of metabolic inhibitors in a randomized, open-la... |
|
|
Chronic angle-closure glaucoma related to paroxetine treatment.
Semin. Ophthalmol. 28(4) , 244-6, (2013) To present a unique case of a 33-year-old woman using paroxetine who presented with acute unilateral visual loss due to chronic angle-closure glaucoma.Case report.A 33-year-old women who had been unde... |
|
|
Paroxetine (Brisdelle) for hot flashes.
Med. Lett. Drugs Ther. 55(1428) , 85-6, (2013)
|
| fg7051maleate |
| gf74 |
| MFCD01742665 |
| Paroxetine maleate |